$69.72
0.140.19%
In chiusura: -
$68.88
-0.84-1.20%
After hour: Aug 29, 7:04 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Corcept Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 29
Stima EPS
$0.190
Stima dei ricavi trimestrali
$224.04M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$716.08M
Analizza lo storico degli utili di Corcept Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CORT | Corcept Therapeutics | $0.41 | $0.19 | — | — | $182.55M | $224.04M | — | — | 10/29/2025 | |
CORT | Corcept Therapeutics | $0.32 | $0.20 | $0.29 | 45.00% | $163.77M | $201.27M | $194.43M | -3.40% | 07/31/2025 | |
CORT | Corcept Therapeutics | $0.25 | $0.14 | $0.17 | 21.43% | $146.81M | $177.93M | $157.21M | -11.64% | 05/05/2025 | |
CORT | Corcept Therapeutics | $0.28 | $0.37 | $0.26 | -29.73% | $135.41M | $195.74M | $181.89M | -7.08% | 02/26/2025 | |
CORT | Corcept Therapeutics | $0.28 | $0.28 | $0.41 | 46.43% | $123.60M | $171.97M | $182.55M | 6.15% | 10/30/2024 | |
CORT | Corcept Therapeutics | $0.25 | $0.23 | $0.32 | 39.13% | $117.72M | $155.23M | $163.77M | 5.50% | 07/29/2024 | |
CORT | Corcept Therapeutics | $0.14 | $0.22 | $0.25 | 13.64% | $105.65M | $140.80M | $146.81M | 4.27% | 05/01/2024 | |
CORT | Corcept Therapeutics | $0.14 | $0.26 | $0.28 | 7.69% | $103.06M | $129.30M | $135.41M | 4.72% | 02/15/2024 | |
CORT | Corcept Therapeutics | $0.30 | $0.21 | $0.28 | 33.33% | $101.73M | $119.34M | $123.60M | 3.57% | 11/01/2023 | |
CORT | Corcept Therapeutics | $0.24 | $0.15 | $0.25 | 66.67% | $103.39M | $109.71M | $117.72M | 7.30% | 08/02/2023 | |
CORT | Corcept Therapeutics | $0.20 | $0.19 | $0.14 | -26.32% | $93.70M | $104.87M | $105.65M | 0.75% | 05/03/2023 | |
CORT | Corcept Therapeutics | $0.35 | $0.22 | $0.14 | -36.36% | $98.82M | $105.08M | $103.06M | -1.93% | 02/28/2023 | |
CORT | Corcept Therapeutics | $0.30 | $0.22 | $0.30 | 36.36% | $96.13M | $107.59M | $101.73M | -5.45% | 11/03/2022 | |
CORT | Corcept Therapeutics | $0.30 | $0.21 | $0.24 | 14.29% | $91.59M | $101.00M | $103.39M | 2.36% | 08/03/2022 | |
CORT | Corcept Therapeutics | $0.20 | $0.24 | $0.20 | -16.67% | $79.44M | $98.88M | $93.70M | -5.24% | 05/05/2022 | |
CORT | Corcept Therapeutics | $0.27 | $0.21 | $0.35 | 66.67% | $85.73M | $100.57M | $98.82M | -1.74% | 02/15/2022 | |
CORT | Corcept Therapeutics | $0.24 | $0.20 | $0.30 | 50.00% | $86.33M | $97.19M | $96.13M | -1.09% | 11/03/2021 | |
CORT | Corcept Therapeutics | $0.32 | $0.16 | $0.30 | 87.50% | $88.56M | $86.84M | $91.59M | 5.47% | 07/29/2021 | |
CORT | Corcept Therapeutics | $0.34 | $0.21 | $0.20 | -4.76% | $93.25M | $91.81M | $79.44M | -13.48% | 05/06/2021 | |
CORT | Corcept Therapeutics | $0.33 | $0.19 | $0.27 | 42.11% | $87.89M | $87.77M | $85.73M | -2.32% | 02/23/2021 | |
CORT | Corcept Therapeutics | $0.31 | $0.20 | $0.24 | 20.00% | $81.50M | $90.87M | $86.33M | -5.00% | 11/03/2020 |
Corcept Therapeutics (CORT) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $0.29 | $0.20 | 45.0 % |
| Q1 | 2025-05-05 | $0.17 | $0.14 | 21.4 % |
| Q4 | 2025-02-26 | $0.26 | $0.37 | -29.7 % |
| Q3 | 2024-10-30 | $0.41 | $0.28 | 46.4 % |
Corcept Therapeutics (CORT) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-07-31 | $194.43M | $201.27M | -3.40 % |
| Q1 | 2025-05-05 | $157.21M | $177.93M | -11.6 % |
| Q4 | 2025-02-26 | $181.89M | $195.74M | -7.08 % |
| Q3 | 2024-10-30 | $182.55M | $171.97M | 6.15 % |
FAQ
Quando Corcept Therapeutics (NASDAQ:CORT) riporterà gli utili?
Si prevede che Corcept Therapeutics (CORT) fornisca risultati il ottobre 29, 2025. Gli ultimi risultati sono stati pubblicati il luglio 31, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Corcept Therapeutics (NASDAQ:CORT)?
L'EPS effettivo era $0.29, che superato la stima di $0.20.
Quali sono state le entrate di Corcept Therapeutics (NASDAQ:CORT)?
Le entrate effettive sono state $194.4M, che mancato la stima di $201.3M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.